Cargando…
Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis of family history of breast or ovarian cancers. The pu...
Autores principales: | Brozek, Izabela, Ratajska, Magdalena, Piatkowska, Magdalena, Kluska, Anna, Balabas, Aneta, Dabrowska, Michalina, Nowakowska, Dorota, Niwinska, Anna, Rachtan, Jadwiga, Steffen, Jan, Limon, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496543/ https://www.ncbi.nlm.nih.gov/pubmed/22395474 http://dx.doi.org/10.1007/s10689-012-9519-5 |
Ejemplares similares
-
Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011) -
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
por: Kluska, Anna, et al.
Publicado: (2017) -
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015) -
A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2010) -
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
por: Niwinska, Anna, et al.
Publicado: (2020)